ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -12.5% | 34,182 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 34,182 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -47.4% | 34,182 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -45.7% | 34,182 | 0.0% | 0.00% | – |
| Q3 2021 | $35,000 | -25.5% | 34,182 | 0.0% | 0.00% | – |
| Q2 2021 | $47,000 | -87.7% | 34,182 | -84.8% | 0.00% | – |
| Q1 2021 | $382,000 | +30.4% | 224,939 | -4.8% | 0.00% | – |
| Q4 2020 | $293,000 | -15.3% | 236,256 | -2.9% | 0.00% | – |
| Q3 2020 | $346,000 | +15.7% | 243,420 | -1.5% | 0.00% | – |
| Q2 2020 | $299,000 | +9.1% | 247,090 | +6.2% | 0.00% | – |
| Q1 2020 | $274,000 | -46.9% | 232,586 | -4.8% | 0.00% | – |
| Q4 2019 | $516,000 | -4.1% | 244,346 | 0.0% | 0.00% | – |
| Q3 2019 | $538,000 | -16.3% | 244,346 | -3.8% | 0.00% | – |
| Q2 2019 | $643,000 | +195.0% | 253,974 | +306.1% | 0.00% | – |
| Q1 2019 | $218,000 | +40.6% | 62,542 | -6.9% | 0.00% | – |
| Q4 2018 | $155,000 | -7.2% | 67,149 | +55.1% | 0.00% | – |
| Q3 2018 | $167,000 | +12.1% | 43,283 | -1.6% | 0.00% | – |
| Q2 2018 | $149,000 | +22.1% | 44,003 | -24.5% | 0.00% | – |
| Q1 2018 | $122,000 | +10.9% | 58,263 | +7.2% | 0.00% | – |
| Q4 2017 | $110,000 | -64.9% | 54,329 | -20.1% | 0.00% | – |
| Q3 2017 | $313,000 | +114.4% | 67,961 | 0.0% | 0.00% | – |
| Q2 2017 | $146,000 | -58.9% | 67,961 | -39.7% | 0.00% | – |
| Q1 2017 | $355,000 | +29.1% | 112,682 | +6.6% | 0.00% | – |
| Q4 2016 | $275,000 | -43.5% | 105,740 | -15.5% | 0.00% | – |
| Q3 2016 | $487,000 | +24.6% | 125,162 | -14.0% | 0.00% | – |
| Q2 2016 | $391,000 | +111.4% | 145,477 | +142.4% | 0.00% | – |
| Q1 2016 | $185,000 | +25.0% | 60,018 | +56.3% | 0.00% | – |
| Q4 2015 | $148,000 | +26.5% | 38,402 | 0.0% | 0.00% | – |
| Q3 2015 | $117,000 | -28.2% | 38,402 | 0.0% | 0.00% | – |
| Q2 2015 | $163,000 | -72.7% | 38,402 | -75.1% | 0.00% | – |
| Q1 2015 | $596,000 | -46.3% | 154,388 | -6.4% | 0.00% | – |
| Q4 2014 | $1,110,000 | +27.1% | 164,892 | +3.7% | 0.00% | – |
| Q3 2014 | $873,000 | -69.5% | 158,991 | -43.1% | 0.00% | – |
| Q2 2014 | $2,866,000 | +72.2% | 279,582 | +101.8% | 0.00% | – |
| Q1 2014 | $1,664,000 | +13.2% | 138,576 | +6.6% | 0.00% | – |
| Q4 2013 | $1,470,000 | -58.8% | 129,955 | -60.7% | 0.00% | -100.0% |
| Q3 2013 | $3,568,000 | +153.8% | 330,966 | +118.2% | 0.00% | – |
| Q2 2013 | $1,406,000 | – | 151,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |